Brooklyn Capital Management »

Cyteir Therapeutics shares owned by Brooklyn Capital Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Brooklyn Capital Management from 13F filings

Historical chart of Brooklyn Capital Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Brooklyn Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Brooklyn Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $608k 200k 3.04
2023-09-30 $568k 200k 2.84

More positions owned by Brooklyn Capital Management

Boulder Growth & Income Fund (STEW)
General American Investors (GAM)
Dws Municipal Income Cf non-tax cef (KTF)
Cion Invt Corp (CION)
Central Securities (CET)
Texas Pacific Land Corp (TPL)
Neuberger Berman Next Genera Common Stock (NBXG)
Bny Mellon Mun Income (DMF)
Inflection Pt Acquisitn Crp Cl A Ord Shs (IPXX)
Fs Kkr Capital Corp (FSK)
Haymaker Acquisition Corp Iv Class A (HYAC)
Ap Acquisition Corp Cl A Ord Shs (APCA)
Global Lights Acquisition Ord Shs (GLAC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Virtus Global Divid Income F (ZTR)

View all positions for Brooklyn Capital Management

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics